The shuttle walking test: a reproducible method for evaluating the impact of shortness of breath on functional capacity in patients with advanced cancer
S. Booth et L. Adams, The shuttle walking test: a reproducible method for evaluating the impact of shortness of breath on functional capacity in patients with advanced cancer, THORAX, 56(2), 2001, pp. 146-150
Background-Breathlessness leading to exercise limitation is common in patie
nts with advanced cancer and is ineffectively treated. There are few resear
ch data to guide clinicians on best practice. The shuttle walking test has
been validated for some conditions such as chronic obstructive pulmonary di
sease but not for advanced cancer. One of the well documented difficulties
of doing clinical research in palliative care is the acceptability of asses
sment tests. This study examined the reproducibility of the shuttle walking
test in patients with advanced cancer to help facilitate the systematic ev
aluation of interventions designed to improve breathlessness.
Methods-Patients performed three shuttle walks on separate days with contin
uous monitoring of arterial oxygen saturation and heart rate; simple pulmon
ary function (FEV,) was also recorded. Data on quality of life, anxiety, an
d depression were collected throughout the study period using appropriate q
uestionnaires. Breathlessness was measured before and after exercise using
a visual analogue scale. Results-Data from 22 patients were compared betwee
n visits 2 and 3. There were no significant differences between the FEV, (1
.89 v 1.90, p=0.73), distance walked on each test (245 m v 256 m, p=0.14),
end-exercise levels of heart rate (107/min v 108/min, p=0.11), oxygen satur
ation (93.4% v 93.2%, p=0.38), or breathlessness scores (p=0.62) on the two
occasions. Indices of quality of life, anxiety, and depression were also n
ot different between the two tests. The investigation was very acceptable t
o patients, families, and staff.
Conclusions-The shuttle walking test is a reproducible test of functional c
apacity in ambulant patients with advanced cancer, WHO performance status I
or 2. The data indicate that a practice session is needed. It is easy to c
arry out and acceptable for patients with advanced cancer. (Thorax 2001;56:
146-150).